Press Releases

All Releases
View Summary Ironwood Pharmaceuticals Provides Third Quarter 2016 Investor Update
Nov 3, 2016
PDF 103.9 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Present at Credit Suisse 25th Annual Healthcare Conference
Nov 1, 2016
PDF 12.7 KB Add to Briefcase
View Summary Ironwood Highlights Breadth of Gout Research with Presentations at the American College of Rheumatology 2016 Annual Meeting
Oct 25, 2016
PDF 26.7 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Host Third Quarter 2016 Investor Update Call
Oct 20, 2016
PDF 13.0 KB Add to Briefcase
View Summary Nine in Ten Physicians Agree Target Goal for Gout Is Imperative, Yet Half of Patients Fail to Reach It, New Survey Shows
Oct 3, 2016
PDF 17.0 KB Add to Briefcase
View Summary Ironwood Announces U.S. Availability of ZURAMPIC® (lesinurad) 200 mg Tablets for Patients with Uncontrolled Gout
Oct 3, 2016
PDF 77.6 KB Add to Briefcase
View Summary Ironwood Closes $150 Million Debt Refinancing
Sep 26, 2016
PDF 14.7 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference
Sep 7, 2016
PDF 12.7 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Present at Wells Fargo 2016 Healthcare Conference
Sep 1, 2016
PDF 12.6 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Provides Second Quarter 2016 Investor Update
Aug 4, 2016
PDF 102.0 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Host Second Quarter 2016 Investor Update Call
Jul 21, 2016
PDF 13.1 KB Add to Briefcase
View Summary Ironwood and Allergan Announce Supplemental New Drug Application for 72 mcg Linaclotide in Chronic Idiopathic Constipation Has Been Accepted for FDA Review
Jun 9, 2016
PDF 601.9 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Present at Jefferies 2016 Healthcare Conference
Jun 6, 2016
PDF 12.6 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Closes U.S. Transaction with AstraZeneca for Lesinurad
Jun 3, 2016
PDF 20.7 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Present at Goldman Sachs 37th Annual Global Healthcare Conference
Jun 1, 2016
PDF 12.8 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Present at 2016 UBS Global Healthcare Conference
May 18, 2016
PDF 9.6 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Present Linaclotide Data at Digestive Disease Week® 2016
May 17, 2016
PDF 333.1 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Provides First Quarter 2016 Investor Update
May 9, 2016
PDF 98.5 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Present at Bank of America Merrill Lynch 2016 Health Care Conference
May 3, 2016
PDF 12.7 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Enters into U.S. Licensing Agreement with AstraZeneca for Lesinurad
Apr 26, 2016
PDF 296.4 KB Add to Briefcase
Showing 21-40 of 231 Page: 1 2 3 4 5 6 ... 12  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase
You are now leaving ironwoodpharma.com. This link will take you to
a website to which our privacy policy does not apply. You are solely
responsible for your interactions with that website.